Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17851812 [patent_doc_number] => 20220281854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => COMBINATION THERAPY FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/751153 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/751153
COMBINATION THERAPY FOR TREATING CANCER May 22, 2022 Abandoned
Array ( [id] => 18065743 [patent_doc_number] => 20220396830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => BIOLUMINESCENT DETECTION OF DNA SYNTHESIS [patent_app_type] => utility [patent_app_number] => 17/744255 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744255
BIOLUMINESCENT DETECTION OF DNA SYNTHESIS May 12, 2022 Pending
Array ( [id] => 18065743 [patent_doc_number] => 20220396830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => BIOLUMINESCENT DETECTION OF DNA SYNTHESIS [patent_app_type] => utility [patent_app_number] => 17/744255 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744255
BIOLUMINESCENT DETECTION OF DNA SYNTHESIS May 12, 2022 Pending
Array ( [id] => 17790445 [patent_doc_number] => 20220249536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => ANTIBODY DRUG CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/730924 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730924
Antibody drug conjugates Apr 26, 2022 Issued
Array ( [id] => 17807418 [patent_doc_number] => 20220259253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => CD73 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/722513 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -123 [patent_words_short_claim] => 1087 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/722513
CD73 INHIBITORS Apr 17, 2022 Abandoned
Array ( [id] => 19650016 [patent_doc_number] => 12171776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Methods for treatment and prophylaxis of HIV and AIDS [patent_app_type] => utility [patent_app_number] => 17/658547 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9805 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/658547
Methods for treatment and prophylaxis of HIV and AIDS Apr 7, 2022 Issued
Array ( [id] => 17704962 [patent_doc_number] => 20220204968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 17/695270 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/695270
LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS Mar 14, 2022 Pending
Array ( [id] => 18109631 [patent_doc_number] => 20230002511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/681971 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681971
High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof Feb 27, 2022 Issued
Array ( [id] => 17670944 [patent_doc_number] => 20220184111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY [patent_app_type] => utility [patent_app_number] => 17/682655 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/682655
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY Feb 27, 2022 Abandoned
Array ( [id] => 17687687 [patent_doc_number] => 20220194979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN [patent_app_type] => utility [patent_app_number] => 17/674860 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674860
Method for preparing delphinium acylated anthocyanin Feb 17, 2022 Issued
Array ( [id] => 18091303 [patent_doc_number] => 20220409644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/674032 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674032
ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE Feb 16, 2022 Abandoned
Array ( [id] => 17642270 [patent_doc_number] => 20220170008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME [patent_app_type] => utility [patent_app_number] => 17/674177 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674177
POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME Feb 16, 2022 Pending
Array ( [id] => 17642270 [patent_doc_number] => 20220170008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME [patent_app_type] => utility [patent_app_number] => 17/674177 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674177
POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME Feb 16, 2022 Pending
Array ( [id] => 19441229 [patent_doc_number] => 12091470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers [patent_app_type] => utility [patent_app_number] => 17/667707 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36004 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667707
Use of poly alpha-1,3-glucan ethers as viscosity modifiers Feb 8, 2022 Issued
Array ( [id] => 17865361 [patent_doc_number] => 20220288096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER [patent_app_type] => utility [patent_app_number] => 17/588507 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588507
COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER Jan 30, 2022 Abandoned
Array ( [id] => 17593483 [patent_doc_number] => 20220143056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/584129 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/584129
METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES Jan 24, 2022 Pending
Array ( [id] => 17593483 [patent_doc_number] => 20220143056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/584129 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/584129
METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES Jan 24, 2022 Pending
Array ( [id] => 20192217 [patent_doc_number] => 20250268927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => SYNBIOTIC TREATMENT REGIMENS [patent_app_type] => utility [patent_app_number] => 18/261012 [patent_app_country] => US [patent_app_date] => 2022-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261012 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261012
SYNBIOTIC TREATMENT REGIMENS Jan 11, 2022 Pending
Array ( [id] => 20192217 [patent_doc_number] => 20250268927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => SYNBIOTIC TREATMENT REGIMENS [patent_app_type] => utility [patent_app_number] => 18/261012 [patent_app_country] => US [patent_app_date] => 2022-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261012 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261012
SYNBIOTIC TREATMENT REGIMENS Jan 11, 2022 Pending
Array ( [id] => 19098302 [patent_doc_number] => 20240117530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => Continuous Dissolution of a Cellulose Derivative [patent_app_type] => utility [patent_app_number] => 18/270241 [patent_app_country] => US [patent_app_date] => 2021-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11581 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270241
Continuous Dissolution of a Cellulose Derivative Dec 30, 2021 Pending
Menu